| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/15/2008 | US20080113014 Method for Screening for Compounds Safe for Gastric Mucosa |
| 05/15/2008 | US20080113013 topical multicompartments in the form of a patches comprising pressure sensitive adhesive polymer matrices containing drugs and permeation enhancers; drug delivery devices; controlled release |
| 05/15/2008 | US20080113012 Method for using transdermal system with fentanyl |
| 05/15/2008 | US20080113011 drug mixture comprising interferons, gelatin, phosphatidylcholine didecanoyl, methyl-beta-cyclodextrin, ethylenediamine tetraacetic acid and benzalkonium chloride, having improved pharmacokinetics, used for treating autoimmune and viral diseases, by administering to mucous membranes |
| 05/15/2008 | US20080113008 Absorbent fabric implant |
| 05/15/2008 | US20080113007 Amniotic membrane having fibrinogen and thrombin attached on a surface; transplantation material for reconstructing the ocular surface or the skin; transparency and strength; excellent in biological affinity, low immunogenicity; no suturing necessary |
| 05/15/2008 | US20080113006 Transparent Sheet-Like Cleansing Agent |
| 05/15/2008 | US20080113005 Composition Comprising an Extract of Gramineae Plant for the Prevention and Treatment of Ischemic Diseases and Degenerative Brain Diseases and the Use Thereof |
| 05/15/2008 | US20080113004 Gallium complex; pain, itching, allodynia, hyperalgesia, peripheral neuropathic pain associated with postherpetic neuralgia. |
| 05/15/2008 | US20080113002 Contact lens compositions |
| 05/15/2008 | US20080112994 Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium |
| 05/15/2008 | US20080112991 Method of enhancing skin absorption of nutrients and active agents |
| 05/15/2008 | US20080112989 Encapsulation method |
| 05/15/2008 | US20080112987 Coating for oxygen sensitive materials |
| 05/15/2008 | US20080112986 Controlled release sterile injectable aripiprazole formulation and method |
| 05/15/2008 | US20080112985 Controlled release sterile injectable aripiprazole formulation and method |
| 05/15/2008 | US20080112972 Preservation of bioactive materials by freeze dried foam |
| 05/15/2008 | US20080112932 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112931 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112915 Skin disorders; metabolic disorders; gene therapy; biocompatability |
| 05/15/2008 | US20080112910 Cool feeling composition, cool feeling auxiliary composition, and use thereof |
| 05/15/2008 | US20080112900 Chewable Antiplaque Confectionery Dental Composition |
| 05/15/2008 | US20080112899 Carboxamides and Their Use |
| 05/15/2008 | US20080112896 Microparticles obtained by spray-freeze-drying a solution or dispersion of a water-soluble matrix such as hyaluronic acid and drug; lightweight, porous to deposit deeply in lungs; mucoadhesion; time-release agents |
| 05/15/2008 | US20080112895 Cannabinoids in buffer/cosolvent such as ethanol, propylene glycol and/or polyethylene glycol; ophthalmology |
| 05/15/2008 | US20080112894 Biocompatible Polymer Compounds For Medicinal Formulations |
| 05/15/2008 | US20080112892 X-Ray Visible Drug Delivery Device |
| 05/15/2008 | US20080112886 Engineering shape of polymeric micro- and nanoparticles |
| 05/15/2008 | US20080111269 Granules, tablets and granulation |
| 05/15/2008 | DE202006020224U1 Pharmazeutische Zusammensetzung Pharmaceutical composition |
| 05/15/2008 | CA2669745A1 Method of producing microcapsules |
| 05/15/2008 | CA2669334A1 Polymer-based antimicrobial agents, methods of making said agents, and products and applications using said agents |
| 05/15/2008 | CA2669019A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 05/15/2008 | CA2669009A1 Method for mixing powders |
| 05/15/2008 | CA2668919A1 Oral dosage form comprising tri-substituted glycerol compounds |
| 05/15/2008 | CA2668864A1 Pharmaceutical composition comprising a dihydrobenzofuranyl isoindoline and a lipophilic component |
| 05/15/2008 | CA2668775A1 Melt-processed imatinib dosage form |
| 05/15/2008 | CA2668743A1 Liposome preparation by single-pass process |
| 05/15/2008 | CA2668741A1 Method for the production of an agent against an infectious disease |
| 05/15/2008 | CA2668733A1 Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| 05/15/2008 | CA2668647A1 Granules, tablets and granulation |
| 05/15/2008 | CA2668638A1 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
| 05/15/2008 | CA2668556A1 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 05/15/2008 | CA2668417A1 Alphavirus and alphavirus replicon particle formulations and methods |
| 05/15/2008 | CA2667976A1 Protein-containing agent with increased thermal stability |
| 05/15/2008 | CA2667879A1 A work holder for use in and a method for making a lollipop |
| 05/15/2008 | CA2667724A1 Solid dosage form with a film containing an active substance, as well as its method of production |
| 05/15/2008 | CA2667720A1 Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
| 05/15/2008 | CA2667655A1 Crystalline anti-htnfalpha antibodies |
| 05/15/2008 | CA2667477A1 Transdermal delivery of ketoprofen polar derivatives |
| 05/14/2008 | EP1921094A2 Method for presenting and removing substances |
| 05/14/2008 | EP1921086A1 Antitumor agent |
| 05/14/2008 | EP1920786A1 Oral preparation useful in measuring capacity to metabolize pyridine |
| 05/14/2008 | EP1920785A1 Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| 05/14/2008 | EP1920779A1 Technique for stabilization of yw753 reparation |
| 05/14/2008 | EP1920768A1 Solid dosage form with a film containing an active substance, as well as its method of production |
| 05/14/2008 | EP1920767A1 Melt-processed imatinib dosage form |
| 05/14/2008 | EP1920766A2 Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| 05/14/2008 | EP1920765A1 Liposome preparation by single-pass process |
| 05/14/2008 | EP1920764A1 Fluprostenol isopropyl ester for use in the treatment of glaucoma and ocular hypertension |
| 05/14/2008 | EP1920763A1 Pharmaceutical compositions for inhalation |
| 05/14/2008 | EP1920663A1 Coating for oxygen sensitive materials |
| 05/14/2008 | EP1920257A1 Optically fluorescent nanoparticles |
| 05/14/2008 | EP1919488A1 A composition comprising silver nanoparticles and the use thereof |
| 05/14/2008 | EP1919487A1 Particulate compositions comprising alginate and/or alginic acid |
| 05/14/2008 | EP1919468A2 Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof |
| 05/14/2008 | EP1919467A2 Duloxetine hydrochloride delayed release formulations |
| 05/14/2008 | EP1919462A2 Center-filled chewing gum composition |
| 05/14/2008 | EP1919461A2 Medicinal forms of phospholipid preparations and methods for their preparation |
| 05/14/2008 | EP1919460A2 Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent |
| 05/14/2008 | EP1919459A1 Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier |
| 05/14/2008 | EP1919458A2 Enterically coated cysteamine, cystamine and derivatives thereof |
| 05/14/2008 | EP1919457A2 Stable fixed-dose unitary formulation, containing tenofovir, a sufactant, efavirenz and emtricitabine |
| 05/14/2008 | EP1919456A2 Bazedoxifene acetate formulations and manufacturing process thereof |
| 05/14/2008 | EP1919455A2 Medicinal forms of phospholipid preparations and methods for their preparation |
| 05/14/2008 | EP1919454A2 Dried milled granulate and methods |
| 05/14/2008 | EP1919453A2 Processes for reducing particle size of aripiprazole |
| 05/14/2008 | EP1919452A2 Application of a bioactive agent to a substrate |
| 05/14/2008 | EP1919451A2 Application of a bioactive agent in a solvent composition to produce a target particle morphology |
| 05/14/2008 | EP1919450A1 Antihistamine- and corticosteroid- containing liposome composition and its use for the manufacture of a medicament for treating rhinitis and related disorders |
| 05/14/2008 | EP1919449A2 Antibiotic kit and composition and uses thereof |
| 05/14/2008 | EP1919448A2 Vasoactive kit and composition and uses thereof |
| 05/14/2008 | EP1919447A2 Compositions and methods for making and using nanoemulsions |
| 05/14/2008 | EP1919446A2 Method for treating skin irritations such as diaper rash and the like |
| 05/14/2008 | EP1919445A1 Controlled release of hypnotic agents |
| 05/14/2008 | EP1919444A2 Polyethylene glycol based composition for topical treatment of a closed wound with therapeutic pharmaceuticals |
| 05/14/2008 | EP1919438A2 Oral care composition |
| 05/14/2008 | EP1919295A2 Coated chewable confection |
| 05/14/2008 | EP1919288A2 Medicaments containing famotidine and ibuprofen and administration of same |
| 05/14/2008 | EP1848406B1 Peroral solid dosage form for contraception comprising dienogest and ethinylestradiol |
| 05/14/2008 | EP1734922A4 Antimicrobial compositions |
| 05/14/2008 | EP1696825A4 Use of alginate matrices to control cell growth |
| 05/14/2008 | EP1684729B1 Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances |
| 05/14/2008 | EP1651274B1 Bioadhesive gel based on hydroxyethylcellulose |
| 05/14/2008 | EP1633440B1 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 05/14/2008 | EP1622584B1 Pharmaceutical effervescent formulation comprising amoxycillin and clavulanic acid |
| 05/14/2008 | EP1496875B1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix |
| 05/14/2008 | EP1469832B1 Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| 05/14/2008 | EP1418890B1 Propellant-based microparticle formulations |
| 05/14/2008 | EP1390023B1 Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds |